Next Article in Journal
Molecular Basis for Drug Resistance in HIV-1 Protease
Previous Article in Journal
The Future of HCV Therapy: NS4B as an Antiviral Target
Viruses 2010, 2(11), 2493-2508; doi:10.3390/v2112493

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs

*  and
McGill University AIDS Centre, Jewish General Hospital, 3755 Cote-Ste-Catherine Road, Montreal, Quebec, H3T 1E2, Canada
* Author to whom correspondence should be addressed.
Received: 8 October 2010 / Revised: 26 October 2010 / Accepted: 28 October 2010 / Published: 11 November 2010
Download PDF [108 KB, uploaded 12 May 2015]


Despite the fact that over 90% of HIV-1 infected people worldwide harbor non‑subtype B variants of HIV-1, knowledge of resistance mutations in non-B HIV-1 and their clinical relevance is limited. Due to historical delays in access to antiretroviral therapy (ART) on a worldwide basis, the vast majority of reports on drug resistance deal with subtype B infections in developed countries. However, both enzymatic and virological data support the concept that naturally occurring polymorphisms among different nonB subtypes can affect HIV-1 susceptibility to antiretroviral drugs (ARVs), the magnitude of resistance conferred by major mutations, and the propensity to acquire some resistance mutations. Tools need to be optimized to assure accurate measurements of drug susceptibility of non-B subtypes. Furthermore, there is a need to recognize that each subtype may have a distinct resistance profile and that differences in resistance pathways may also impact on cross-resistance and the selection of second-line regimens. It will be essential to pay attention to newer drug combinations in well designed long-term longitudinal studies involving patients infected by viruses of different subtypes.
Keywords: HIV; drug resistance; subtypes; reverse transcriptase; protease; integrase HIV; drug resistance; subtypes; reverse transcriptase; protease; integrase
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Wainberg, M.A.; Brenner, B.G. Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs. Viruses 2010, 2, 2493-2508.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert